Cite
TNF-Based Isolated Limb Perfusion Followed by Consolidation Biotherapy with Systemic Low-dose Interferon Alpha 2b in Patients with In-transit Melanoma Metastases: A Pilot Trial.
MLA
Rossi, Carlo, et al. “TNF-Based Isolated Limb Perfusion Followed by Consolidation Biotherapy with Systemic Low-Dose Interferon Alpha 2b in Patients with In-Transit Melanoma Metastases: A Pilot Trial.” Annals of Surgical Oncology: An Oncology Journal for Surgeons, vol. 15, no. 4, Apr. 2008, pp. 1218–23. EBSCOhost, https://doi.org/10.1245/s10434-007-9791-z.
APA
Rossi, C., Russano, F., Mocellin, S., Chiarion-Sileni, V., Foletto, M., Pilati, P., Campana, L., Zanon, A., Picchi, G., Lise, M., & Nitti, D. (2008). TNF-Based Isolated Limb Perfusion Followed by Consolidation Biotherapy with Systemic Low-dose Interferon Alpha 2b in Patients with In-transit Melanoma Metastases: A Pilot Trial. Annals of Surgical Oncology: An Oncology Journal for Surgeons, 15(4), 1218–1223. https://doi.org/10.1245/s10434-007-9791-z
Chicago
Rossi, Carlo, Francesco Russano, Simone Mocellin, Vanna Chiarion-Sileni, Mirto Foletto, Pierluigi Pilati, Luca Campana, et al. 2008. “TNF-Based Isolated Limb Perfusion Followed by Consolidation Biotherapy with Systemic Low-Dose Interferon Alpha 2b in Patients with In-Transit Melanoma Metastases: A Pilot Trial.” Annals of Surgical Oncology: An Oncology Journal for Surgeons 15 (4): 1218–23. doi:10.1245/s10434-007-9791-z.